Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

1. A European Academy of Neurology guideline on medical management issues in dementia

A European Academy of Neurology guideline on medical management issues in dementia European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness D. Kondziella a,b,c , A. Bender d,e , K. Diserens f , W. van Erp g,h , A. Estraneo i,j , R. Formisano k , S. Laureys g , L. Naccache l,m , S. Ozturk n , B. Rohaut l,m,o , J. D. Sitt m , J. Stender p , M. Tiainen q , A. O. Rossetti f, *, O. Gosseries g, * , and C. Chatelle g,r, * on behalf of the EAN Panel on Coma

2020 European Academy of Neurology

2. Care Interventions for People Living With Dementia and Their Caregivers

Care Interventions for People Living With Dementia and Their Caregivers Comparative Effectiveness Review Number 231 Care Interventions for People Living With Dementia and Their Caregivers Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00008-I Prepared by: Minnesota Evidence-based Practice Center Minneapolis, MN Investigators: Mary Butler, Ph.D., M.B.A. Joseph E (...) , the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report. Suggested citation: Butler M, Gaugler JE, Talley KMC, Abdi HI, Desai PJ, Duval S, Fort ML, Nelson VA, NG W, Ouellette JM, Ratner E, Saha J, Shippee T, Wagner BL, Wilt TJ, Yeshi L. Care Interventions for People Living With Dementia and Their Caregivers. Comparative Effectiveness Review No. 231. (Prepared

2020 Effective Health Care Program (AHRQ)

3. Recommendations of the 5th Canadian Consensus Conferenceon the diagnosis and treatment of dementia

Recommendations of the 5th Canadian Consensus Conferenceon the diagnosis and treatment of dementia Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia error_outline JavaScript disabled You have to enable JavaScript in your browser's settings in order to use the eReader. Or try downloading the content offline

2020 CPG Infobase

4. Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs Full Text available with Trip Pro

Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) of Nottingham, Nottingham, UK 4 Faculty of Health and Social Care, Centre of Psychological Care and Ageing, University of Hull, Hull, UK 5 Dementia Service Development Centre, Wales Dementias & Neurodegenerative Diseases Network, Bangor University, Bangor, UK 6 Whitaker Research Ltd, Bangor, UK 7 Centre for Age-related Medicine, Stavanger University Hospital, University of Stavanger, Stavanger, Norway 8 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK 9 London School

2020 NIHR HTA programme

5. Amyloid PET in dementia of unclear aetiology

Amyloid PET in dementia of unclear aetiology 1 Translation of the executive summary of the assessment of potential Amyloid-PET bei Demenz unklarer Ätiologie (Version 1.0; Status: 29 May 2018). Please note: This translation is provided as a service by IQWiG to English- language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. E18-03 Amyloid PET in dementia of unclear aetiology 1 Extract of assessment (...) of potential E18-03 Version 1.0 Amyloid PET in dementia of unclear aetiology 29 May 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Amyloid PET in dementia of unclear aetiology Commissioning agency: Federal Joint Committee Commission awarded on: 18 April 2018 Internal Commission No.: E18-03 Address of publisher: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Im Mediapark 8 50670

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

6. Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03)

Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03) 1 Translation of the executive summary of the addendum Amyloid-PET bei Demenz unklarer Ätiologie – Addendum zum Auftrag E18-03 (Version 1.0; Status: 19 July 2018). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. E18-05 Amyloid PET in dementia (...) of unclear aetiology Addendum to Commission E18-03 1 Extract of addendum E18-05 Version 1.0 Amyloid PET in dementia of unclear aetiology 19 July 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Amyloid PET in dementia of unclear aetiology – Addendum to Commission E18-03 Commissioning agency: Federal Joint Committee Commission awarded on: 1 June 2018 Internal Commission No.: E18-05 Address

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

7. Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Full Text available with Trip Pro

Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study found a relatively high prevalence of dementia/mild cognitive impairment in prisons and it developed a care pathway and training materials for staff and prisoners. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , & . Katrina Forsyth 1 , Leanne Heathcote 1 , Jane Senior 1, * , Baber Malik 1 , Rachel Meacock 1 , Katherine Perryman 1 , Sue Tucker 1 , Rachel

2020 NIHR HTA programme

8. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis

Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show account info (...) Page navigation Metabolism Actions . 2020 May 22;109:154265. doi: 10.1016/j.metabol.2020.154265. Online ahead of print. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis , , , , Affiliations Expand Affiliations 1 Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, China. Electronic address: jbzhou@ccmu.edu.cn. 2 Beijing Tongren Hospital, Capital Medical University, China. 3 Department of Nephrology, Tongji Medical College, Huazhong

2020 EvidenceUpdates

9. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis Full Text available with Trip Pro

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Age Ageing Actions . 2020 Jun 29;afaa090. doi: 10.1093/ageing/afaa090. Online ahead of print. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 University of East Anglia, Norwich, UK. 2 James Paget Hospital, Gorleston, UK. 3 Aston University, Birmingham, UK. 4 University of Aberdeen, Aberdeen, UK. 5

2020 EvidenceUpdates

10. Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial

Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Randomized Controlled Trial Arch Phys Med Rehabil Actions . 2020 May;101(5):762-769. doi: 10.1016/j.apmr.2020.01.012. Epub 2020 Feb 19. Therapeutic Effects of Exercise Training on Elderly Patients With Dementia: A Randomized Controlled Trial , , , , , Affiliations Expand Affiliations 1 Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung, Taiwan. 2 Department of Neurology

2020 EvidenceUpdates

11. Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences Full Text available with Trip Pro

Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences Advance Care Planning for People Living With Dementia: An Umbrella Review of Effectiveness and Experiences - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review Int J Nurs Stud Actions . 2020 Jul;107:103576. doi: 10.1016/j.ijnurstu.2020.103576. Epub 2020 Mar 20. Advance Care Planning for People Living With Dementia: An Umbrella Review of Effectiveness and Experiences , , , , , Affiliations Expand Affiliations 1 End-of-Life Care Research Group, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium. Electronic address: Annelien.van.dael@vub.be. 2 Centre

2020 EvidenceUpdates

12. End of Life Care in Frailty: Dementia

End of Life Care in Frailty: Dementia End of Life Care in Frailty: Dementia | British Geriatrics Society Toggle main menu visibility Search Search Search Resources (menu position rule) Date Published: 12 May 2020 Last updated: 12 May 2020 The aim of this guidance series is to support clinicians and others to consider the needs of frail older people as they move towards the end of their lives and help them to provide high quality care. This chapter addresses specific issues which may arise (...) in people living with dementia towards the end of life. Please to view the other chapters in this series. Dementia is a condition that kills. According to one study, 1 the average life expectancy from diagnosis to death is 4.5 years, and average survival rate in this study varied from a high of 10.7 years for the youngest patients (65-69 years) to a 3.8 years for the people diagnosed after their 90 th birthday. People may die with dementia because of the dementia itself (which may lead to poor mobility

2020 British Geriatrics Society

13. Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials

Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Age Ageing Actions . 2020 May 6;afaa063. doi: 10.1093/ageing/afaa063. Online ahead of print. Cognitive Training Interventions and Depression in Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , , , , , Affiliations Expand Affiliations 1 Department

2020 EvidenceUpdates

14. Effectiveness of different post-diagnostic dementia care models delivered by primary care: a systematic review

Effectiveness of different post-diagnostic dementia care models delivered by primary care: a systematic review Effectiveness of Different Post-Diagnostic Dementia Care Models Delivered by Primary Care: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Br J Gen Pract Actions . 2020 May 28;70(695):e434-e441. doi: 10.3399/bjgp20X710165. Print 2020 Jun. Effectiveness of Different Post-Diagnostic Dementia Care Models Delivered by Primary Care: A Systematic Review , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Primary Care and Population Health, University College London, London, UK. 2 Saw Swee Hock School of Public Health, National

2020 EvidenceUpdates

15. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline Full Text available with Trip Pro

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline Randomized Placebo-Controlled Trial of the Effects of Aspirin on Dementia and Cognitive Decline - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology (...) Actions Cite Share Permalink Copy Page navigation Neurology Actions . 2020 Mar 25;10.1212/WNL.0000000000009277. doi: 10.1212/WNL.0000000000009277. Online ahead of print. Randomized Placebo-Controlled Trial of the Effects of Aspirin on Dementia and Cognitive Decline , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 From the School of Public Health and Preventive Medicine (J.R., E.S., R.L.W., R.W., C.M.R., S.A.W., J.E.L., S.G.O., R.T., J.J.M.) and the Turner Institute for Brain

2020 EvidenceUpdates

16. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. (Abstract)

Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. The benefit of blood pressure lowering for the prevention of dementia or cognitive impairment is unclear.To determine the association of blood pressure lowering with dementia or cognitive impairment.Search of PubMed, EMBASE, and CENTRAL for randomized clinical trials published from database inception through December 31, 2019, that evaluated the association of blood (...) pressure lowering on cognitive outcomes. The control groups consisted of either placebo, alternative antihypertensive agents, or higher blood pressure targets.Data were screened and extracted independently by 2 authors. Random-effects meta-analysis models were used to report pooled treatment effects and CIs.The primary outcome was dementia or cognitive impairment. The secondary outcomes were cognitive decline and changes in cognitive test scores.Fourteen randomized clinical trials were eligible

2020 JAMA

17. Covid-19: Dementia and cognitive disorders

Covid-19: Dementia and cognitive disorders Dementia Scientific Panel Report - COVID-19 - eanpages COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 Executive Page May 1, 2020 Executive Page April 1, 2020 Executive Page March 1, 2020 Executive Page February 1, 2020 Country of the Month May 1, 2020 Country of the Month April 5, 2020 Country of the Month March 1, 2020 Country (...) January 3, 2020 Patients societies reports January 2, 2020 Surveys April 10, 2020 Surveys October 7, 2019 Forum April 1, 2016 Forum March 1, 2016 Forum March 1, 2016 Forum February 1, 2016 Uncategorized May 2, 2020 Uncategorized May 1, 2020 Uncategorized May 1, 2020 Uncategorized April 29, 2020 Dementia Scientific Panel Report – COVID-19 April 3, 2020 During the Covid-19 pandemic, most European countries have imposed personal restrictions on their populations in order to inhibit viral transmission

2020 European Academy of Neurology

18. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia

Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review Comparative Effectiveness Review Number 223 RComparative Effectiveness Review Number 223 Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00008-I (...) , M.F.A. Nancy L. Greer, Ph.D. Kerry M. Sheets, M.D. Timothy J. Wilt, M.D., M.P.H. Mary Butler, Ph.D., M.B.A. AHRQ Publication No. 20-EHC003 April 2020 Key Messages Purpose of Review To summarize evidence on cognitive test accuracy for clinical Alzheimer’s-type dementia (CATD) in suspected cognitive impairment; biomarker accuracy for Alzheimer’s disease (AD) in dementia; and effects of CATD drug treatment. Key Messages • Many brief cognitive tests were highly (>0.8) sensitive and specific

2020 Effective Health Care Program (AHRQ)

19. Covid-19: ALS and frontotemporal dementia

Covid-19: ALS and frontotemporal dementia Amyotrophic Lateral Sclerosis and COVID-19 – Recommendations to patients and caregivers - eanpages COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 COVID-19 May 13, 2020 COVID-19 May 13, 2020 COVID-19 May 6, 2020 COVID-19 May 6, 2020 Executive Page May 1, 2020 Executive Page April 1, 2020 Executive Page March 1, 2020 Executive Page February 1, 2020 Country of the Month May 1, 2020 Country of the Month April 5, 2020 (...) (ALS), the impact of respiratory infections is expected to be more serious than in the general population, due to the weakness of the respiratory muscles and limitations in coughing (1-4). ALS patients with impaired respiratory function and/or rapid clinical deterioration are considered a high risk population for COVID-19 (5), even if no estimates in the different European countries are available. ENCALS centres and the EAN panel on ALS and Frontotemporal Dementia are working together across

2020 European Academy of Neurology

20. Covid-19: Advice for aged care providers – residents with dementia

Covid-19: Advice for aged care providers – residents with dementia Advice for aged care providers – residents with dementia 27 APRIL 2020 This advice provides information that may help to: i. reduce transmission of COVID-19 from resident to resident in aged residential care ii. maintain care and quality of life for residents with dementia or cognitive impairment. This advice is additional to, and should be read alongside, other guidance provided for health professionals and specifically (...) for aged residential care, which can be found on health.govt.nz/covid-19. Preventing COVID-19 in residents with dementia COVID-19 is highly contagious. We recognise that social distancing for residents with dementia may be difficult to maintain, and may heighten their anxiety and agitation. Increased staffing may be needed. You and your staff are in a good position to manage the care and wellbeing of your residents with dementia. This includes thinking about, preparing and communicating with residents

2020 Covid-19 Ad hoc guidelines